Bristol-Myers Squibb

Day One of JPM Brings Excitement and Promise for a New Year in Biotech and Pharma
BioSpace
Wed, 01/9/19 - 09:40 am
JPMHC 2019
M&A
Eli Lilly
Loxo Oncology
SAGE Therapeutics
Sanofi
Regeneron
Bristol-Myers Squibb
Celgene
Novartis
Gilead Sciences
3 Things Bristol-Myers Squibb Understands About Celgene That the Market Hasn't
Motley Fool
Tue, 01/8/19 - 12:43 am
Celgene
Bristol-Myers Squibb
M&A
JPMHC 2019
Celgene invested $30M in NantCell weeks before BMS bid
BioCentury
Tue, 01/8/19 - 12:41 am
Celgene
NantCell
Bristol-Myers Squibb
M&A
Why the Bristol-Myers Squibb Acquisition Is a Bad Deal for Celgene
Motley Fool
Sun, 01/6/19 - 11:08 pm
Bristol-Myers Squibb
Celgene
M&A
After Bristol-Myers Squibb Buys Celgene What's Next? JP Morgan's Conference Will Answer That
Forbes
Sat, 01/5/19 - 03:04 pm
Celgene
Bristol-Myers Squibb
M&A
JPMHC 2019
BMS CEO Giovanni Caforio Lays out Reasoning for $74 Billion Acquisition of Celgene
BioSpace
Sat, 01/5/19 - 03:08 pm
Bristol-Myers Squibb
M&A
Giovanni Caforio
Celgene
Johns Hopkins, Bristol-Myers must face $1 bln syphilis infections suit
Yahoo/Reuters
Sat, 01/5/19 - 01:36 pm
Bristol-Myers Squibb
federal lawsuit
Johns Hopkins
Could Gilead, Amgen and AbbVie follow Bristol-Myers into megadeal territory?
Fierce Pharma
Sat, 01/5/19 - 01:34 pm
M&A
Bristol-Myers Squibb
Celgene
Gilead Sciences
AbbVie
Amgen
Celgene executives whipped up new, lucrative severance plans ahead of Bristol-Myers megadeal
Fierce Pharma
Sat, 01/5/19 - 12:12 am
Bristol-Myers Squibb
Celgene
M&A
severance
executive pay
The BMS-Celgene merger’s Achilles heel? An earlier-than-expected Revlimid patent loss
Fierce Pharma
Fri, 01/4/19 - 11:59 pm
Bristol-Myers Squibb
Celgene
M&A
Revlimid
patents
Should Celgene Investors Take Bristol's Money and Run?
Motley Fool
Fri, 01/4/19 - 10:01 am
Celgene
Bristol-Myers Squibb
M&A
Here’s What Bristol-Myers Squibb Will Look Like After Acquiring Celgene
Yahoo/Motley Fool
Fri, 01/4/19 - 09:14 am
M&A
Celgene
Bristol-Myers Squibb
Bristol-Myers Squibb And Celgene's Big Winner? Los Angeles Billionaire Patrick Soon-Shiong
Forbes
Thu, 01/3/19 - 11:47 pm
Patrick Soon-Shiong
Bristol-Myers Squibb
Celgene
M&A
BMS deal weighs on Celgene partners
BioCentury
Thu, 01/3/19 - 11:45 pm
M&A
Celgene
Bristol-Myers Squibb
Acceleron
BeiGene
Bristol-Myers to buy Celgene in industry-shaking $74B deal
Biopharma Dive
Thu, 01/3/19 - 09:50 am
M&A
Bristol-Myers Squibb
Celgene
immuno-oncology
Andexxa will go nationwide with FDA nod on Portola's commercial production of the bleeding antidote
Fierce Pharma
Wed, 01/2/19 - 11:38 am
Portola Pharmaceuticals
AndexXa
Pfizer
Bristol-Myers Squibb
JNJ
Bayer
FDA
anticoagulant reversal
Report: Pharma companies kick off new year with price hikes
Drug Delivery Business News
Wed, 01/2/19 - 10:11 am
Allergan
Bristol-Myers Squibb
Biogen
Pfizer
drug pricing
New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases
BioSpace
Fri, 12/28/18 - 01:30 pm
breast cancer
lung cancer
AstraZeneca
Tagrisso
Novartis
Gleevec
Tasigna
Bristol-Myers Squibb
Sprycel
Pfizer
Bosulif
Takeda
Iclusig
15 For ’19: Key Clinical Data To Watch For Next Year (Part 1)
Xconomy
Mon, 12/17/18 - 09:44 am
clinical trials
Alzheimer's disease
Biogen
Duchenne Muscular Dystrophy
Pfizer
Solid Biosciences
Sarepta Therapeutics
hemophilia A
Biomarin
Multiple Myeloma
Celgene
Bluebird Bio
Amgen
solid tumors
Bristol-Myers Squibb
Nektar Therapeutics
age-related macular degeneration
Regenxbio
SAGE Therapeutics
MorphoSys
Taisho Nears $1.6 Billion Deal for Bristol-Myers Unit
Bloomberg
Mon, 12/17/18 - 12:20 am
Taisho
Bristol-Myers Squibb
OTC
Upsa
M&A

Pages